Outcomes in Patients With Breast Cancer or Prostate Cancer Receiving Antiresorptive Therapy for Bone Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study
J Bone Oncol 2022 Apr 01;33(2022)100420, A Jakob, MO Zahn, A Nusch, T Werner, R Schnell, M Frank, N Hamm, KU Däßler, C Losem, M Welslau, P Hoevel, K PotthoffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.